Multiple Sclerosis Expert Dr. Alfred Sandrock from Myelin Repair Foundation Joins the Myelin Repair Foundation’s Clinical Advisory Board

SARATOGA, Calif.--(BUSINESS WIRE)--The Myelin Repair Foundation (MRF), the only foundation focused on the discovery and development of myelin repair therapeutics for multiple sclerosis (MS), today announced the appointment of Dr. Alfred Sandrock to its Clinical Advisory Board. As Senior Vice President, Development Sciences and Chief Medical Officer at Biogen Idec (NASDAQ: BIIB), Dr. Sandrock joins fellow MRF Clinical Advisory Board members to bring unparalleled MS expertise from both the biotechnology industry and academic research to the Myelin Repair Foundation.